UnknownNot Applicable

The Efficacy of Platelets Rich Plasma Injection With PRGF Method in the Treatment for Osteoarthritis of the Subtalar Joint

Israel30 participantsStarted 2011-08

Plain-language summary

The investigators will try to find any efficacy of platelet rich plasma injection for the treatment of osteoarthritis (OA) in the subtalar joint. Autologous platelet-secreted growth factors (GFs) may have therapeutic effects in OA capsular joints via multiple mechanisms. The investigators aim is to examine the effect of a platelet-derived preparation rich in growth factors(PRGFs) in OA of the subtalar joint, using parameters of pain, function, quality of life and safety.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female age 18-70 * Diagnosed OA of subtalar joint * Patients who didn't benefit from other conservative treatments * Patients who are willing to participate in the trial Exclusion criteria: * Non ambulatory * Pregnant or lactating women * Patient with containment disease that may affect joint * Patient with open wounds; or skin disease; suspected joint infection: in the treated area * Patients with a specific condition or poor general health status that will interfere with the functional assessments during the study or who had intraarticular injection or have had surgery within the previous 3 months

What they're measuring

Improvement in function and activity level in subtalar joint with osteoarthritis

Timeframe: 1 year

improvement in pain in subtalar osteoarthritis

Timeframe: 1 year

Trial details

NCT IDNCT01422460

SponsorMeir Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-06

Contact for this trial

Lior Laver, M.D

: +972-50-8464466 laver17@gmail.com

View on ClinicalTrials.gov More Osteoarthritis of Subtalar Joint trials